Hasegawa Kohei, Mansbach Jonathan M, Teach Stephen J, Fisher Erin S, Hershey Daniel, Koh Joyce Y, Clark Sunday, Piedra Pedro A, Sullivan Ashley F, Camargo Carlos A
From the *Department of Emergency Medicine, Massachusetts General Hospital; †Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA; ‡Division of Emergency Medicine, Children's National Health System, Washington, DC; §Department of Pediatrics, Rady Children's Hospital, University of California San Diego, San Diego; ¶Division of Hospital Medicine, Children's Hospital Los Angeles, Los Angeles, CA; ‖Department of Emergency Medicine, Weill Cornell Medical College, New York, NY; and **Departments of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX.
Pediatr Infect Dis J. 2014 Aug;33(8):809-13. doi: 10.1097/INF.0000000000000293.
It is unclear whether the infectious etiology of severe bronchiolitis affects short-term outcomes, such as posthospitalization relapse. We tested the hypothesis that children hospitalized with rhinovirus (RV) bronchiolitis, either as a sole pathogen or in combination with respiratory syncytial virus (RSV), are at increased risk of relapse.
We performed a 16-center, prospective cohort study of hospitalized children age <2 years with bronchiolitis. During the winters of 2007-2010, researchers collected clinical data and nasopharyngeal aspirates from study participants; the aspirates were tested using real-time polymerase chain reaction. The primary outcome was bronchiolitis relapse (urgent bronchiolitis visit or scheduled visit at which additions to the bronchiolitis medications were made) during the 2 weeks after hospital discharge.
Among 1836 enrolled children with 2-week, follow-up data, the median age was 4 months and 60% were male. Overall, 48% had sole RSV infection, 8% had sole RV infection, and 13% had RSV/RV coinfection. Compared with children with sole RSV infection, and adjusting for 10 demographic and clinical characteristics and clustering of patients within hospitals, children with sole RV infection did not differ in their likelihood of relapse (odds ratio: 0.99; 95% confidence interval: 0.52-1.90; P = 0.98), whereas those with RSV/RV coinfection were more likely to have relapse (odds ratio: 1.54; 95% confidence interval: 1.03-2.30; P = 0.03).
In this prospective, multicenter, multiyear study of children hospitalized with bronchiolitis, we found that RSV/RV coinfection was independently associated with a higher likelihood of bronchiolitis relapse. Present data support the concept that the infectious etiology of severe bronchiolitis affects short-term outcomes.
严重细支气管炎的感染病因是否会影响短期预后,如出院后复发,目前尚不清楚。我们检验了这样一个假设,即因鼻病毒(RV)细支气管炎住院的儿童,无论是单一病原体感染还是与呼吸道合胞病毒(RSV)合并感染,复发风险都会增加。
我们对16个中心年龄小于2岁的住院细支气管炎患儿进行了一项前瞻性队列研究。在2007年至2010年冬季,研究人员收集了研究参与者的临床数据和鼻咽吸出物;吸出物采用实时聚合酶链反应进行检测。主要结局是出院后2周内细支气管炎复发(紧急细支气管炎就诊或进行细支气管炎药物加量的预约就诊)。
在1836名有2周随访数据的入组儿童中,中位年龄为4个月,60%为男性。总体而言,48%为单纯RSV感染,8%为单纯RV感染,13%为RSV/RV合并感染。与单纯RSV感染的儿童相比,在调整了10个人口统计学和临床特征以及医院内患者聚集情况后,单纯RV感染的儿童复发可能性没有差异(比值比:0.99;95%置信区间:0.52 - 1.90;P = 0.98),而RSV/RV合并感染的儿童更易复发(比值比:1.54;95%置信区间:1.03 - 2.30;P = 0.03)。
在这项对住院细支气管炎患儿进行的前瞻性、多中心、多年研究中,我们发现RSV/RV合并感染与细支气管炎复发的较高可能性独立相关。现有数据支持严重细支气管炎的感染病因会影响短期预后这一概念。